Search results for " Relative Risk"
showing 3 items of 3 documents
An Extension of the DgLARS Method to High-Dimensional Relative Risk Regression Models
2020
In recent years, clinical studies, where patients are routinely screened for many genomic features, are becoming more common. The general aim of such studies is to find genomic signatures useful for treatment decisions and the development of new treatments. However, genomic data are typically noisy and high dimensional, not rarely outstripping the number of patients included in the study. For this reason, sparse estimators are usually used in the study of high-dimensional survival data. In this paper, we propose an extension of the differential geometric least angle regression method to high-dimensional relative risk regression models.
Comparing air quality indices aggregated by pollutant
2011
In this paper a new aggregate Air Quality Index (AQI) useful for describing the global air pollution situation for a given area is proposed. The index, unlike most of currently used AQIs, takes into account the combined effects of all the considered pollutants to human health. Its good performance, tested by means of a simulation plan, is confirmed by a comparison with two other indices proposed in the literature, one of which is based on the Relative Risk of daily mortality, considering an application to real data.
Risk of thyroid as a first or second primary cancer. A population-based study in Italy, 1998–2012
2021
Abstract Background The number of patients living after a cancer diagnosis is increasing, especially after thyroid cancer (TC). This study aims at evaluating both the risk of a second primary cancer (SPC) in TC patients and the risk of TC as a SPC. Methods We analyzed two population‐based cohorts of individuals with TC or other neoplasms diagnosed between 1998 and 2012, in 28 Italian areas covered by population‐based cancer registries. Standardized incidence ratios (SIRs) of SPC were stratified by sex, age, and time since first cancer. Results A total of 38,535 TC patients and 1,329,624 patients with other primary cancers were included. The overall SIR was 1.16 (95% CI: 1.12–1.21) for SPC i…